NEWS

July 30, 2026 The Honorable Ron Wyden Ranking Member Committee on Finance United States Senate 219 Dirksen Senate Office Building Washington, D.C. 20510 Re: We Work For Health Response to Commonsense Policy Options to Lower Drug Prices for Patients Request for Information Dear Senator Wyden: We Work For Health (WWFH) appreciates the opportunity to respond to Ranking Member Wyden’s Request for Information, “Commonsense Policy Options to Lower Drug Prices for Patients.” We shar

July 22, 2026 Senate Committee on Health, Education, Labor and Pensions 428 Senate Dirksen Office Building Washington, DC, 20510 Re: July 22 Senate HELP Committee Markup Dear Members of the Senate Committee on Health, Education, Labor and Pensions: On behalf of We Work For Health (WWFH), a coalition of national and local business leaders, labor organizations, biopharmaceutical companies, patient advocates and other healthcare stakeholders united in support of policies

July 20, 2026 House Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, D.C. 20515 Re: July 20 House E&C Committee Markup Dear Members of the House Committee on Energy and Commerce: On behalf of We Work For Health (WWFH), a coalition of national and local business leaders, labor organizations, biopharmaceutical companies, patient advocates and other healthcare stakeholders united in support of policies that foster innovation and facilitate

We Work For Health Executive Director Dan Leonard sent a letter to Senate HELP Committee members ahead of a June 17 mark-up of legislation that will have broad implications for U.S. innovation, patient access and national security. Lawmakers were urged to reject proposals that could expose sensitive IP, increase litigation, undermine patent certainty, and weaken the innovation ecosystem. To learn more about the importance of IP protections, please see the following resources

We Work For Health Executive Director Dan Leonard sent a letter to the Subcommittee ahead of its hearing, emphasizing the importance of robust intellectual property (IP) protections in the development of breakthrough medicines. Visit the WWFH IP page to learn more about the importance of IP protections.

We Work For Health Executive Director Dan Leonard recently sent a letter to the Food and Drug Administration (FDA) commending its commitment to expanding domestic drug research and manufacturing capabilities. He also urged the agency to encourage continued progress in fortifying the nation’s pharmaceutical supply chain. For more on how U.S. investments are driving innovation, explore WWFH's Biopharma Investment Watch .

We Work For Health Executive Director Dan Leonard's recently wrote a letter to the White House, encouraging a pause in the implementation...

Dear Chairman Sanders, Ranking Member Cassidy, and Members of the Committee: The American medical innovation infrastructure that has...

Meena Seshamani, M.D., Ph.D. CMS Deputy Administrator and Director of the Center for Medicare Centers for Medicare & Medicaid Services...

The International Association of Fire Fighters' General President, Edward Kelly, sent the following letter to U.S. Secretary of Commerce...

As Americans prepare for Christmas and the holiday season, the House of Representatives passed legislation to codify Trump administration...

Read We Work For Health's letter that was sent to the Biden Administration. Washington, DC (February 7, 2023) – At We Work For Health, we...